Skip to main content

Table 6 Clinical outcomes in the GnRH antagonist and GnRH agonist groups

From: Impact of GnRH analogues on oocyte/embryo quality and embryo development in in vitro fertilization/intracytoplasmic sperm injection cycles: a case control study

Clinical outcome

GnRH antagonist

GnRH agonist

Pvalue

embryotransfer performed (%)

91.0 (91/100)

94.0 (94/100)

0.58

transferred embryos (mean + SD)

2.59 (± 0.87)

2.84 (± 0.83)

0.06

cryopreservation performed (%)

17.0 (17/100)

28.0 (28/100)

0.09

cryopreserved embryos (mean + SD)

4.29 (± 1.92)

4.64 (± 2.04)

0.57

clinical pregnancy rate (%)/ET

30.8 (28/91)

40.4 (38/94)

0.17

clinical pregnancy rate (%)/cycle

28.0 (28/100)

38.0 (38/100)

0.13

implatation rate (%)

19.1 (45/236)

20.6 (55/267)

0.67